Michéle Boisdron-Celle

Title: Michéle Boisdron-Celle: Innovator in Personalized Medicine

Introduction

Michéle Boisdron-Celle is a notable inventor based in Saint Leger Des Bois, France. He has made significant contributions to the field of personalized medicine, particularly in cancer treatment. His innovative approach focuses on optimizing drug dosages to enhance patient outcomes.

Latest Patents

One of his key patents is titled "Individual 5-fluorouracile dose optimization in FOLFIRI treatment." This invention pertains to a method for progressively optimizing the 5-FU dose administered by continuous infusion in patients undergoing a FOLFIRI regimen. The method utilizes the 5-FU plasmatic concentration measured during previous infusions, along with a decision algorithm designed to improve treatment efficacy. This patent represents a significant advancement in personalized cancer therapy.

Career Highlights

Throughout his career, Michéle Boisdron-Celle has worked with esteemed institutions such as the Institut de Cancérologie de l'Ouest and the Université d'Angers. His work in these organizations has allowed him to collaborate with leading experts in the field of oncology and personalized medicine.

Collaborations

Some of his notable coworkers include Erick Gamelin and Alain Morel. Their collaborative efforts have contributed to advancements in cancer treatment methodologies.

Conclusion

Michéle Boisdron-Celle's innovative work in optimizing cancer treatment through personalized medicine exemplifies the impact of targeted therapies in improving patient care. His contributions continue to influence the field and inspire future research.